Halozyme Therapeutics (GB:0J2O)
LSE:0J2O

Halozyme (0J2O) Financial Statements

1 Followers

Halozyme Financial Overview

Halozyme's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Halozyme is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $0.76. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 195.88M$ 230.04M$ 216.03M$ 221.04M$ 162.14M
Gross Profit$ 167.55M$ 177.74M$ 161.21M$ 170.97M$ 126.97M
EBIT$ 100.53M$ 106.39M$ 106.27M$ 97.65M$ 56.78M
EBITDA$ 120.16M$ 127.09M$ 129.74M$ 118.68M$ 78.13M
Net Income Common Stockholders$ 76.82M$ 85.39M$ 68.64M$ 74.75M$ 39.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 463.45M$ 336.00M$ 483.28M$ 348.27M$ 275.61M
Total Assets$ 1.84B$ 1.73B$ 1.89B$ 1.81B$ 1.70B
Total Debt$ 1.50B$ 1.50B$ 1.50B$ 1.50B$ 1.49B
Net Debt$ 1.04B$ 1.16B$ 1.01B$ 1.15B$ 1.22B
Total Liabilities$ 1.66B$ 1.65B$ 1.64B$ 1.66B$ 1.63B
Stockholders Equity$ 177.81M$ 83.81M$ 249.18M$ 151.03M$ 65.85M
Cash Flow-
Free Cash Flow$ 125.88M$ 99.76M$ 129.47M$ 68.47M$ 75.56M
Operating Cash Flow$ 129.43M$ 102.35M$ 132.41M$ 66.85M$ 86.94M
Investing Cash Flow$ -82.68M$ -8.29M$ -83.45M$ 54.99M$ -60.16M
Financing Cash Flow$ -489.00K$ -249.92M$ 4.10M$ 2.45M$ -164.61M
Currency in USD

Halozyme Earnings and Revenue History

Halozyme Debt to Assets

Halozyme Cash Flow

Halozyme Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis